Posted on 07/26/2009 4:19:57 PM PDT by MyTwoCopperCoins
MUMBAI: For 15 years, Rakesh Singh (name changed) went about his high-pressure job as a senior engineer in a central government firm with a transplanted kidney.
Daily, he would pop immuno-suppressant pills to prevent his body from rejecting the donated organ. Then, about 18 months ago, he was struck by an "explosive" form of cancer called multiple myeloma big cysts erupted across and within his body, impairing his ability to sign and speak.
Singh's disease put doctors in the city's Jaslok Hospital in a bind about what line of treatment to follow: reducing the immuno-suppressants to let his body fight the cancer cells could have led to a possible rejection of the kidney.
It was then decided to give him a second transplant of the bone marrow this time with his own stem cells. Today, Singh is cancer-free and a medical marvel of sorts.
It has been a month since the 49-year-old underwent a PET (positron emission tomography) scan that categorically showed that he had no more cancer cells in his body. He has been breathing easy since then, but the doctors who treated him over 18 months have got a tad busier: they have a big announcement to make to the world.
Papers are being written, archives are being rechecked and old-timers being consulted before the doctors submit their claim to Nephrology Dialysis Transplant, a European journal.
"Singh is the first kidney transplant patient in the world to undergo a stem cell transplant to beat multiple myeloma (a cancer of the plasma cell) after ablative chemotherapy," say nephrologist Dr Madan Bahadur, hematologist Dr Sameer Shah and oncologist Dr Ganpati Bhat.
KEM Hospital's head of nephrology department, Dr V Hase, says, "The Jaslok patients case is of great academic interest. Firstly, it is rare for a kidney transplant patient to develop multiple myeloma. Secondly, no transplant patient in India has undergone a stem cell transplant as a rescue mission against cancer.
Dr Hase adds that renal failure is a known complication of multiple myeloma. So, in the western world, multiple myeloma patients would undergo stem cell transplant first and a renal transplant later, he says. But in the Mumbai case, the opposite has happened.
As for the man who underwent the Rs 19-lakh (US$ 38,000 approx.) rescue, life in the last 18 months has been a struggle for survival. He smiles as he recalls the difficulty he had in signing papers.
Well said.
This may be news for India, but it happens quite often in the US. Autologous (from self) stem cell transplants are used to treat a variety of malignancies including lymphoma, leukemia, myeloma and others.
The stem cells are removed from the patient through a special separation process and stored. The cancer and remaining bone marrow are destroyed with high dose radiation and chemo, then the stem cells are reinfused.
They are referring to using it in patients with compromised kidneys. That’s what is new, as far as I can understand.
bttt
Great post and message. Thank you!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.